Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK163090 is a specific and orally active 5-HT1A/B/D receptor antagonist (pKis: 9.4/8.5/9.7, and 6.3/6.7 for 5-HT1A/B/D, and dopamine D2/D3).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 68.00 | |
5 mg | In stock | $ 158.00 | |
10 mg | In stock | $ 269.00 | |
25 mg | In stock | $ 453.00 | |
50 mg | In stock | $ 666.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 169.00 |
Description | GSK163090 is a specific and orally active 5-HT1A/B/D receptor antagonist (pKis: 9.4/8.5/9.7, and 6.3/6.7 for 5-HT1A/B/D, and dopamine D2/D3). |
Targets&IC50 | 5-HT1A:9.4 (pKi), 5-HT1B:8.5 (pKi), 5-HT1D:9.7 (pKi) |
In vitro | GSK163090 demonstrates clear dose-dependent inhibition of the 8-OH-DPAT-induced hyper locomotor activity (hLMA), with ED50 values ranging from 0.03 to 1 mg/kg. GSK163090 was devoid of agonist activity at R1 receptors, but rather it demonstrated a moderate functional antagonism of the phenylephrine-induced contraction of rabbit aorta (pIC50: 6.9). |
In vivo | The superior quality of GSK163090 was further highlighted by its commendable in vivo pharmacokinetic profile in rats and its outstanding activity in the 5-HT1A PD model, where 50% efficacy was achieved at a blood concentration of 3 ng/mL. |
Molecular Weight | 415.53 |
Formula | C25H29N5O |
CAS No. | 844903-58-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 14.29 mg/mL (34.39 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK163090 844903-58-8 GPCR/G Protein Neuroscience Dopamine Receptor 5-HT Receptor 5-HT1A Inhibitor 5-hydroxytryptamine Receptor GSK 163090 antidepressant anxiolytic SerT inhibit 5-HT1B 5-HT1D GSK-163090 Serotonin Receptor P-glycoprotein inhibitor